The LOTTI study found that patients who interrupted their highly active retroviral therapy (HAART) drugs for AIDS fared as well as those who took the toxic drugs continuously. In fact, more than one-fourth of those who quit their drugs never needed to start taking them again!
Structured Intermittent Therapy (STI) lowered the effects of toxicity, reduced treatment cost, and did not result in drug resistance.
Pharma funded AIDS sites, such as thebody.com, poz.com and aidsmed.com, are not actively informing their readers of the exciting results from this randomized, controlled, prospective study, which was published in the journal AIDS. Information is an essential component for making informed decisions!